Cerebrolysin
Primary research interestCognitive performance & neuroprotection research
Peptide-enriched brain extract studied and used clinically for cognitive and neurological indications.
Cognitive research examines peptides being studied for their potential effects on memory, learning, focus, and neuroplasticity. This page reviews current scientific literature on peptide candidates for cognitive performance and brain health research.
Last updated: 23 April 2026
Cognitive research investigates neuropeptides and neurotrophin-related compounds for memory enhancement, neuroprotection, and cognitive resilience. Cerebrolysin is a polyactive neuropeptide mixture studied for BDNF upregulation and neuroprotection. Semax is examined for cognitive enhancement and stress resilience. Selank is investigated for anxiety reduction and cognitive performance. Research focuses on synaptic plasticity, BDNF signalling, and cognitive outcomes.
Cerebrolysin shows cognitive benefits in post-stroke and age-related cognitive decline populations, with documented BDNF increases. Semax research demonstrates improved memory and attention in human cognitive tasks, particularly in stress contexts. Selank studies suggest anxiolytic effects and improved cognitive performance in anxious populations.
Most cognitive peptide research is concentrated in Eastern European/Russian populations; Western replication is limited. Long-term safety and efficacy in healthy cognitive populations are underexplored. Mechanisms of action at the molecular level remain partially elucidated. Head-to-head comparisons with established nootropics are sparse.
Cognitive peptides are not ARTG-approved for cognitive enhancement or nootropic use. Some (cerebrolysin) may have limited medical application pathways in Australia; most are research-use only. Prescription access is not available for cognitive optimisation. Research-grade supply is legal for institutional research.
Primary research interestCognitive performance & neuroprotection research
Peptide-enriched brain extract studied and used clinically for cognitive and neurological indications.
Primary research interestCognitive performance & neuroprotection research
Russian-origin synthetic peptide studied for cognitive and neuroprotective effects.
Primary research interestCognitive performance & neuroprotection research
Russian-origin synthetic peptide studied for anxiolytic and cognitive effects.
Primary research interestSleep architecture & circadian research
Delta-sleep-inducing peptide with a long research history but limited modern human evidence.
Primary research interestCognitive performance & neuroprotection research
Russian-origin synthetic peptide studied for anxiolytic and cognitive effects.